TM-1803

N/A

Report date: 2025/06/11 10:29:31
NME

Base Information

Drug NameTM-1803
Drug Alias NameS-acetyl-(S)-4'-phosphopantetheine calciumP-PantSAcbiochemical metabolism modulator (Acies Bio/University Medical Center Groningen)CAB-1803TM-1803
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsPantothenate kinase modulators
TargetsPantothenate kinase
Therapy Area/IndicationsPantothenate Kinase-Associated Neurodegeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsSlovenia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcies Bio doo
China Registration ClassN/A

Develop Information

Active CompaniesComet Therapeutics Inc
Active IndicationsPantothenate Kinase-Associated Neurodegeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A